Literature DB >> 2991604

Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells.

M L Smiley, H M Friedman.   

Abstract

Neuraminidase treatment of cells infected with herpes simplex virus type 1 (HSV-1) markedly enhanced the binding of complement component C3b to HSV 1 glycoprotein C (gC). When HSV-1 was grown in BHK RicR14 cells in which glycoproteins had reduced amounts of N-linked complex oligosaccharides, including sialic acid, the binding of C3b to gC was markedly enhanced. We used neuraminidase treatment to demonstrate that cloning the gC gene from the HSV-1 F strain into an HSV-1 mutant which fails to express gC converted the mutant virus from C3b receptor negative to receptor positive. These results further support a role for gC as a C3b receptor and indicate that sialic acid modifies receptor activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991604      PMCID: PMC255075     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  The isolation and properties of a variant of Herpes simplex producing multinucleated giant cells in monolayer cultures in the presence of antibody.

Authors:  M D HOGGAN; B ROIZMAN
Journal:  Am J Hyg       Date:  1959-09

2.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

3.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties.

Authors:  S P McTaggart; W H Burns; D O White; D C Jackson
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

6.  Characteristics of the Fc receptor induced by herpes simplex virus.

Authors:  J Costa; C Yee; Y Nakamura; A Rabson
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

7.  An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization.

Authors:  T Maciag; J Cerundolo; S Ilsley; P R Kelley; R Forand
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Variants of hamster fibroblasts resistant to Ricinus communis toxin (ricin).

Authors:  A Meager; A Ungkitchanukit; R C Hughes
Journal:  Biochem J       Date:  1976-01-15       Impact factor: 3.857

9.  Neuraminidase treatment of human T lymphocytes: effect on Fc receptor phenotype and function.

Authors:  R S Schulof; G Fernandes; R A Good; S Gupta
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

10.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  16 in total

Review 1.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.

Authors:  K Ikeda; H Wakimoto; T Ichikawa; S Jhung; F H Hochberg; D N Louis; E A Chiocca
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.

Authors:  H M Friedman; J C Glorioso; G H Cohen; J C Hastings; S L Harris; R J Eisenberg
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.

Authors:  E Trybala; J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.

Authors:  H M Friedman; L Wang; N O Fishman; J D Lambris; R J Eisenberg; G H Cohen; J Lubinski
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Dextran sulfate can act as an artificial receptor to mediate a type-specific herpes simplex virus infection via glycoprotein B.

Authors:  A P Dyer; B W Banfield; D Martindale; D M Spannier; F Tufaro
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2.

Authors:  C Seidel-Dugan; M Ponce de Leon; H M Friedman; L F Fries; M M Frank; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.

Authors:  M Bröker; K J Abel; R Köhler; J Hilfenhaus; E Amann
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

9.  Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.

Authors:  H P Huemer; C Larcher; M P Dierich; D Falke
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  A block in glycoprotein processing correlates with small plaque morphology and virion targetting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1.

Authors:  J W Dick; K S Rosenthal
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.